Company Overview and News

0
Maruti Suzuki India expands reach of Ecstar products

2018-07-19 moneycontrol
The country's largest car maker Maruti Suzuki India (MSI) today expanded the reach of its Ecstar branded lubricants, coolant and car care products with the introduction of the range at 3,400 workshops under its Arena network. MSI had launched the Ecstar brand of engine oil at workshops under its premium outlet chain NEXA in September last year.
MARUTI 7269 MRZUY 532500

0
Suzuki eyes 40% sales growth at 7 lakh units this fiscal

2018-07-19 moneycontrol
Suzuki Motorcycle India is looking to sell 7 lakh units in the country in the current fiscal, a growth of 40 percent over 5 lakh units it sold during 2017-18. The company, which today launched a new 125-cc scooter Burgman Street priced at Rs 68,000 (ex-showroom), also plans to expand its sales network by around 200 touch points this fiscal as part of its mid term goal of achieving 10 lakh unit sales by 2020.
7269

3
Cars Drive an Upswing in U.S. Retail Sales: 5 Top Auto Picks

2018-07-17 zacks
U.S. retail sales witnessed a solid rise in June as households boosted spending on various products, while demand for automobiles jumped the highest in three months. Continued upswing in retail spending for the fifth straight month has raised expectations of robust economic growth in the second half of 2018. Going forward, an impressive workforce market scenario, higher wage rates and lower taxes will likely stuff more money into wallets and keep demand strong.
VC MGA OSK MG VEEV 7269 MTOR SGH

0
Maruti to roll out new entry-level car in 2020

2018-07-17 livemint
New Delhi: Maruti Suzuki India Ltd, the seller of every second car in the country, plans to introduce its first entry-level car in India in more than two decades, as a revival in rural consumption is expected to boost demand for such vehicles.
MARUTI 7269 MRZUY 532500

4
Tata Motors, Mahindra top RD spenders in auto industry

2018-07-15 moneycontrol
Homegrown companies Tata Motors and Mahindra & Mahindra were the biggest spenders on research and development in 2016-17 among 25 automakers in India which together invested Rs 6,344 crore, latest industry data showed.
BAJAJ-AUTO 532977 505200 CMQMY CUMMINSIND HEROMOTOCO 500477 500570 TATAMOTORS EICHERMOT 500033 ASHOKLEY ECQRY FORCEMOT MRZUY AKLD 532500 500182 500480 MARUTI 7269 501455 HRTQY GREAVESCOT AKLS TTM

4
This week in auto: Suzuki changes stance on electric vehicles in India, Tata Nano nears end of road

2018-07-14 moneycontrol
When the government first mooted the idea of going all-electric by 2030 in terms of mobility, there was widespread criticism and skepticism from all quarters of the automotive industry.
BAJAJ-AUTO TM 7269 7203 TYT 532977 500570 TOYOF TATAMOTORS TTM

0
Maruti will soon go for lithium-ion batteries over lead

2018-07-13 livemint
New Delhi: Suzuki Motor Corp. will fit premium cars sold by its Indian unit with lithium-ion batteries sourced from the parent’s upcoming Gujarat battery plant, starting FY21, two people aware of the development said.
MARUTI 7269 MRZUY 532500

0
Nissan Falsifies Exhaust Emission Data in New Issue for Saikawa - Bloomberg

2018-07-10 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
5406 VLKAF KBSTF MMTOY KBSTY 7269 DDAIF 7211 MMTOF

0
Nissan Says It Found ‘Misconduct' in Exhaust, Fuel Economy Tests - Bloomberg

2018-07-09 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
5406 VLKAF KBSTF MMTOY KBSTY 7269 7211 MMTOF

0
Nissan says it found ‘misconduct’ in exhaust, fuel economy tests

2018-07-09 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
5406 VLKAF KBSTF MMTOY KBSTY 7269 7211 MMTOF

4
Want to sell 1.5 million electric cars a year in India by 2030, says Suzuki chairman

2018-07-09 moneycontrol
Osamu Suzuki, the 88-year-old Chairman of Suzuki Motor Corporation (SMC), has asked the company's executives to target sales of 1.5 million electric cars a year in India by 2030 though its subsidiary Maruti Suzuki.
7269 500570 TATAMOTORS TTM

0
To spite Harley, Trump may have to turn to foreign bike foes

2018-07-04 malaymail
WASHINGTON, July 4 — President Donald Trump added fuel to his feud with Harley-Davidson Inc by claiming he’s working with other motorcycle makers to offset the production its shifting overseas.
KWHIF 7269 KWHIY 7012 PII

0
To spite Harley-Davidson, Trump claims he’s turned to foreign bike rivals to up U.S. output

2018-07-04 japantimes.co.jp
SOUTHFIELD, MICHIGAN/CHICAGO – President Donald Trump added fuel to his feud with Harley-Davidson Inc. by claiming he’s working with other motorcycle makers to offset the production it’s shifting overseas.
KWHIF 7269 KWHIY 7012 PII

3
Auto sales zoom in June, aided by new car launches, low base due to GST

2018-07-02 livemint
Mumbai: Automobile sales that grew in May picked up further speed in June, aided by new model launches and the low base of the previous year. India’s top five carmakers, Maruti Suzuki India Ltd, Hyundai Motor India Ltd, Tata Motors Ltd, Mahindra and Mahindra Ltd and Toyota Kirloskar Motor Pvt. Ltd collectively sold 216,660 units during the month, up 43.7% from 150,772 units a year ago.
MARUTI 7269 500570 TATAMOTORS MRZUY TTM 532500

9
Asia business sentiment slips from 7-year high

2018-06-20 bworldonline
KUALA LUMPUR — Business confidence among Asian companies slipped for the first time in three quarters, on mounting worries that US President Donald Trump’s protectionist policies would trigger tit-for-tat reprisals and undermine the global trading system.
OISHF SMIVY SVTMF OISHY 7269 TRI SM SFTBF 9984 SFTBY DLELY OSH

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...